We're thrilled to lead Telepatia's $33M Series A. (opens in new tab)
We're thrilled to lead Telepatia's $33M Series A. @Nicobot01's father was a physician in Colombia who died at 58 from a drug interaction AI could have flagged in seconds. Nicolás is building the product that could have saved him. Telepatia is the AI-native clinical platform for Latin America spanning an AI scribe, clinical decision support, and AI auditor, each connected to every data source across the hospital. Since launching in July 2025, the platform has deployed across 25+ hospital syste...
Read the original article